Am J Hematol

1. MA S, La J, Swinnerton KN, Guffey D, et al
   Thrombosis risk prediction in lymphoma patients: A multi-institutional, retrospective model development and validation study.
   Am J Hematol. 2024 Apr 23. doi: 10.1002/ajh.27335.
   

   >> Share

   
   

   
   Blood

2. SARKOZY C, Callanan MB, Thieblemont C, Oberic L, et al
   Obinutuzumab versus Rituximab in transplant-eligible Mantle cell lymphoma patients.
   Blood. 2024 Apr 26:blood.2024023944. doi: 10.1182/blood.2024023944.
   

   >> Share

   
   
3. HANDUNNETTI SM, Anderson MA, Burbury KI, Thompson PA, et al
   Seven-year outcomes of venetoclax-ibrutinib therapy in mantle cell lymphoma: durable responses and treatment-free remissions.
   Blood. 2024 Apr 25:blood.2023023388. doi: 10.1182/blood.2023023388.
   

   >> Share

   
   
4. CROCHET G, Iacoboni G, Couturier A, Bachy E, et al
   Efficacy of CAR T-Cell Therapy is Not Impaired by Previous Bispecific Antibody Treatment in Large B-Cell Lymphoma.
   Blood. 2024 Apr 24:blood.2024024526. doi: 10.1182/blood.2024024526.
   

   >> Share

   
   
5. MAYBURY BD, James LJ BSc (Hons), Phillips N, Venkatadasari I, et al
   Testing for t(3;8) in MYC/BCL6 re-arranged large B cell lymphoma identifies a high risk subgroup with inferior survival.
   Blood. 2024 Apr 22:blood.2024024048. doi: 10.1182/blood.2024024048.
   

   >> Share

   
   

   
   Br J Haematol

6. HUO W, Gao L, Song K, Huang J, et al
   Allogeneic haematopoietic stem cell transplantation for adult T-lymphoblastic lymphoma: A real-world multicentre analysis in China.
   Br J Haematol. 2024 Apr 25. doi: 10.1111/bjh.19481.
   

   >> Share

   
   

   
   Cancer Res

7. ITO Y, Marouf A, Kogure Y, Koya J, et al
   Comprehensive genetic profiling reveals frequent alterations of driver genes on the X chromosome in extranodal NK/T-cell lymphoma.
   Cancer Res. 2024 Apr 24. doi: 10.1158/0008-5472.CAN-24-0132.
   

   >> Share

   
   

   
   Curr Treat Options Oncol

8. CHERNG HJ, Herrera A
   Circulating Tumor DNA in Diffuse Large B-Cell Lymphoma: from Bench to Bedside?
   Curr Treat Options Oncol. 2024 Apr 24. doi: 10.1007/s11864-024-01201.
   

   >> Share

   
   

   
   Eur J Haematol

9. KUTSCH N, Godel P, Voltin CA, Hallek M, et al
   Long-term remission in a patient with relapsed Richter's transformation treated with CD19-directed chimeric antigen-receptor T-cells after allogeneic stem cell transplantation.
   Eur J Haematol. 2024;112:984-987.
   

   >> Share

   
   
10. HARMANEN M, Sorigue M, Khan M, Prusila R, et al
    Front-line and second-line treatment for mantle cell lymphoma in clinical practice: A multicenter retrospective analysis.
    Eur J Haematol. 2024 Apr 25. doi: 10.1111/ejh.14219.
    

    >> Share

    
    
11. PERNAS B, Iacoboni G, Los-Arcos I, Carpio C, et al
    Patients with aggressive B-cell lymphoma receiving CAR T-cell therapy have a low rate of severe infections despite lack of universal antibacterial and antifungal prophylaxis.
    Eur J Haematol. 2024 Apr 26. doi: 10.1111/ejh.14207.
    

    >> Share

    
    

    
    Haematologica

12. LINK BK
    Follicular lymphoma treatment decisions: put GELF on the shelf?
    Haematologica. 2024 Apr 24. doi: 10.3324/haematol.2024.285286.
    

    >> Share

    
    

    
    Lab Invest

13. WANG XG, Yin WH, Wang HY
    Indolent T-Cell/Natural Killer-Cell Lymphomas/Lymphoproliferative Disorders of the Gastrointestinal Tract-What Have We Learned in the Last Decade?
    Lab Invest. 2024;104:102028.
    

    >> Share

    
    
14. KAWADE G, Kurata M, Matsuki Y, Fukuda S, et al
    Mediation of Ferroptosis Suppressor Protein 1 Expression via 4-Hydroxy-2-Nonenal Accumulation Contributes to Acquisition of Resistance to Apoptosis and Ferroptosis in Diffuse Large B-Cell Lymphoma.
    Lab Invest. 2024;104:102027.
    

    >> Share

    
    

    
    Leuk Lymphoma

15. VON ROEMELING C, Ferreri AJM, Soussain C, Tun HW, et al
    Targets and treatments in primary CNS lymphoma.
    Leuk Lymphoma. 2024 Apr 24:1-13. doi: 10.1080/10428194.2024.2342560.
    

    >> Share

    
    
16. MCNALLY GA, Aossey CM, Wiczer T, Sinnott LT, et al
    A retrospective cohort study describing chemotherapy-induced peripheral neuropathy in Non-Hodgkin lymphoma patients treated with EPOCH +/- R: does HIV status matter?
    Leuk Lymphoma. 2024 Apr 22:1-7. doi: 10.1080/10428194.2024.2340051.
    

    >> Share

    
    
17. TABARI E, Lovejoy AF, Lin H, Bolen CR, et al
    NGS-determined molecular markers and disease burden metrics from ctDNA correlate with PFS in previously untreated DLBCL.
    Leuk Lymphoma. 2024;65:618-628.
    

    >> Share

    
    
18. TUCCI A, Masina L, Luminari S
    Curative intent therapy for DLBCL in the elderly.
    Leuk Lymphoma. 2024;65:560-569.
    

    >> Share

    
    

    
    Mod Pathol

19. MEDEIROS LJ, Chadburn A, Natkunam Y, Naresh KN, et al
    Fifth Edition of the World Health Classification of Tumors of the Hematopoietic and Lymphoid Tissues: B-cell Neoplasms.
    Mod Pathol. 2024;37:100441.
    

    >> Share

    
    

    
    N Engl J Med

20. HU Y, Zhang M, Yang T, Mo Z, et al
    Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD Prophylaxis.
    N Engl J Med. 2024;390:1467-1480.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

21. LI MY, Chong LC, Duns G, Lytle A, et al
    TRAF3 loss-of-function reveals the noncanonical NF-kappaB pathway as a therapeutic target in diffuse large B cell lymphoma.
    Proc Natl Acad Sci U S A. 2024;121:e2320421121.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share